# OpenSpec Proposal: Phase 2 — Commercial Wedge & Enterprise B2B Assets

## 1. Context & Business Problem
Phase 1 successfully rebuilt SICCE into a hardened, 100% verified clinical translation middleware with zero fabricated data, SQLite FTS5 SNOMED/pharma indexing, Argon2id security, and an active evaluation benchmark.

As defined in `MASTER_DIRECTIVE.md` Section 4, SICCE will NOT be sold directly to individual doctors or compete with ambient scribe tools (HealthPlix, Eka.care). Instead, the high-margin commercial wedge is **"ABDM & NHCX Compliance Engine in a Box"** for:
1. **Small-to-Mid EMR/HIS Vendors (2–5 developer teams)** needing instant ABDM Milestone 1/2 FHIR certification without building custom terminology servers.
2. **Third-Party Administrators (TPAs) & Health Insurers** digitizing legacy physical claim forms and pre-adjudicating claims for IRDAI compliance.

## 2. Goals & Deliverables
1. **1-Page Enterprise Technical Pitch**: Tailored for Indian HIS/EMR CTOs and TPA Chief Claims Officers highlighting the compliance ROI, sub-millisecond local SQLite FTS5 lookups, and CDSS risk reduction.
2. **Enterprise Accuracy Benchmark Report**: Publishing verified Precision, Recall, and F1 metrics (Medication F1: 0.9524, Dosage F1: 0.9474) with methodology and test case transparency.
3. **Developer Sandbox Quickstart & Integration Guide**: Clean 5-minute integration guide with sample cURL, Python, and JavaScript snippets for `/api/v1/parse`, `/api/v1/pre-adjudicate`, and `/api/v1/check-interactions`.
4. **Outreach & Discovery Battlecard**: Ready-to-use LinkedIn & Email outreach templates for the founder targeting HIS CTOs, Hospital Informatics Heads, and TPA Directors.
